Updated overall survival and safety profile of durvalumab monotherapy in advanced NSCLC Meeting Abstract


Authors: Hellmann, M. D.; Antonia, S. J.; Balmanoukian, A. S.; Brahmer, J. R.; Ou, S. H. I.; Kim, S. W.; Ahn, M. J.; Kim, D. W.; Gutierrez, M.; Liu, S. V.; Schoffski, P.; Jaeger, D.; Jamal, R.; Leach, J. W.; Jerusalem, G. H. M.; Lutzky, J.; Nemunaitis, J. J.; Gu, Y.; Abdullah, S. E.; Segal, N. H.
Abstract Title: Updated overall survival and safety profile of durvalumab monotherapy in advanced NSCLC
Meeting Title: 2018 ASCO-SITC Clinical Immuno-Oncology Symposium
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 5 Suppl.
Meeting Dates: 2018 Jan 25-27
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-02-10
Language: English
ACCESSION: WOS:000436177700161
DOI: 10.1200/JCO.2018.36.5_suppl.169
PROVIDER: wos
Notes: Meeting Abstract: 169 -- Source: Wos
Altmetric Score
MSK Authors
  1. Neil Howard Segal
    94 Segal
  2. Matthew David Hellmann
    147 Hellmann